UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

18 F-FDG PET for Measurement of Response and Prediction of Outcome to Relapsed or Refractory Mantle Cell Lymphoma Therapy with Bendamustine–Rituximab

Journal of Nuclear Medicine, 2017-01, Vol.58 (1), p.62-68

2017

Volltextzugriff (PDF)

Abstract CT015: Results from a phase I/II study with the HDAC inhibitor entinostat in combination with high-dose interleukin-2 in renal cell carcinoma patients (CTEP#7870)

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.CT015-CT015

2016

Volltextzugriff (PDF)

Abstract CT015: Results from a phase III study with the HDAC inhibitor entinostat in combination with high-dose interleukin-2 in renal cell carcinoma patients (CTEP7870)

Cancer research (Chicago, Ill.), 2016-07, Vol.76 (14_Supplement), p.CT015-CT015

2016

Volltextzugriff (PDF)

Accelerated Bone Mineral Density Loss Occurs with Similar Incidence and Severity, But with Different Risk Factors, after Autologous versus Allogeneic Hematopoietic Cell Transplantation

Biology of blood and marrow transplantation, 2010-08, Vol.16 (8), p.1130-1137

2010

Volltextzugriff (PDF)

Association of Technetium(99m) MAG-3 renal scintigraphy with change in creatinine clearance following chemoradiation to the abdomen in patients with gastrointestinal malignancies

Journal of gastrointestinal oncology, 2010-09, Vol.1 (1), p.7

2010

Volltextzugriff (PDF)

Bendamustine Plus Rituximab (BR) in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma of a Phase 2 Study: Multivariate Analysis and Updated Final Results By Subgroup

Blood, 2014-12, Vol.124 (21), p.1757-1757

2014

Volltextzugriff (PDF)

Beyond the AJR : 99m Tc-MDP Bone Scintigraphy-Has It Met Its Match?

American journal of roentgenology (1976), 2023-08, Vol.221 (2), p.281-281

2023

Volltextzugriff (PDF)

Bifunctional HPPH - N 2 S 2 - 99m Tc conjugates as tumor imaging agents: synthesis and biodistribution studies

Journal of porphyrins and phthalocyanines, 2003-07, Vol.7 (7), p.500-507

2003

Volltextzugriff (PDF)

Bifunctional HPPH-N2S2-99mTc conjugates as tumor imaging agents: synthesis and biodistribution studies

Journal of porphyrins and phthalocyanines, 2003-07, Vol.7 (7), p.500-507

2003

Volltextzugriff (PDF)

Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of zevalinradioimmunotherapy for low-grade, follicular, or transformed B-cell non-hodgkin's lymphoma

Critical reviews in oncology/hematology, 2001, Vol.39 (1-2), p.181-194

2001

Volltextzugriff (PDF)

Bone scan index at baseline as a tool for predicting hematologic toxicity in metastatic castration-resistant prostate cancer patients eligible for radium-223 treatment

Journal of clinical oncology, 2017-05, Vol.35 (15_suppl), p.e16513-e16513

2017

Volltextzugriff (PDF)

Chapter 104 - 131Iodine in Thyroid Cancer: Use of 131I in the Diagnosis and Therapy of Differentiated Thyroid Carcinoma

Comprehensive Handbook of Iodine, 2009, p.1007-1023

Lamonica, Dominick

2009

Volltextzugriff (PDF)

Clinical and Genetic Factors Underlying Acute Bone Mineral Density Loss by 100 Days after Blood and Marrow Transplantation: A Potential Early Regimen-Related Complication

Blood, 2008-11, Vol.112 (11), p.52-52

2008

Volltextzugriff (PDF)

A Comparative Study of 511 keV SPECT and PET Using Separate 370 MBq F-18-FDG Doses on Different Days

Clinical positron imaging, 1999-03, Vol.2 (2), p.81-91

1999

Volltextzugriff (PDF)

Comprehensive handbook of iodine: nutritional, biochemical, pathological, and therapeutic aspects

1, 2009

Volltextzugriff (PDF)

Disease Control Affects Outcomes of Patients with Relapsed Diffuse Large B Cell Lymphoma Treated with CD19 Directed CAR T-Cell Therapy

Blood, 2023-11, Vol.142 (Supplement 1), p.7376-7376

2023

Volltextzugriff (PDF)

(18)F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study

Leukemia & lymphoma, 2015-07, Vol.56 (7), p.2005-2012

2015

Volltextzugriff (PDF)

High Frequency and Early Onset of Bone Mineral Density Loss Following Allogeneic Stem Cell Transplantation

Blood, 2005-11, Vol.106 (11), p.2011-2011

2005

Volltextzugriff (PDF)

Immunomodulation by entinostat in renal cell carcinoma patients receiving high dose interleukin 2: a multicenter, single-arm, phase 1/2 trial (NCI-CTEP#7870)

Clinical cancer research, 2017-09, Vol.23 (23), p.7199-7208

2017

Volltextzugriff (PDF)

Immunomodulation by HDAC inhibition: Results from a phase II study with entinostat and high-dose interleukin 2 in metastatic renal cell carcinoma patients (CTEP#7870)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.4560-4560

2016

Volltextzugriff (PDF)

Iodine 131 ((131)I) as adjuvant therapy of differentiated thyroid cancer

Surgical oncology clinics of North America, 2004-01, Vol.13 (1), p.129-149

Lamonica, Dominick

2004

Volltextzugriff (PDF)

Iodine 131 ( 131I) as adjuvant therapy of differentiated thyroid cancer

Surgical Oncology Clinics of North America, 2004, Vol.13 (1), p.129-149

Lamonica, Dominick

2004

Volltextzugriff (PDF)

Mammographic and clinical predictors of drainage patterns in breast lymphoscintigrams obtained during sentinel node procedures

Clinical nuclear medicine, 2003-07, Vol.28 (7), p.558-564

2003

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieThe Journal Of Nuclear Medicine

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(21)

Publikationsform

Sprache

Englisch
(39)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

18 F-FDG PET for Measurement of Response and Prediction of Outcome to Relapsed or Refractory Mantle Cell Lymphoma Therapy with Bendamustine–Rituximab

18 F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study

18F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study

Abstract CT015: Results from a phase I/II study with the HDAC inhibitor entinostat in combination with high-dose interleukin-2 in renal cell carcinoma patients (CTEP#7870)

Abstract CT015: Results from a phase III study with the HDAC inhibitor entinostat in combination with high-dose interleukin-2 in renal cell carcinoma patients (CTEP7870)

Accelerated Bone Mineral Density Loss Occurs with Similar Incidence and Severity, But with Different Risk Factors, after Autologous versus Allogeneic Hematopoietic Cell Transplantation

Association of Technetium(99m) MAG-3 renal scintigraphy with change in creatinine clearance following chemoradiation to the abdomen in patients with gastrointestinal malignancies

Bendamustine Plus Rituximab (BR) in the Treatment of Relapsed/Refractory Mantle Cell Lymphoma of a Phase 2 Study: Multivariate Analysis and Updated Final Results By Subgroup

Beyond the AJR : 99m Tc-MDP Bone Scintigraphy-Has It Met Its Match?

Bifunctional HPPH - N 2 S 2 - 99m Tc conjugates as tumor imaging agents: synthesis and biodistribution studies

Bifunctional HPPH-N2S2-99mTc conjugates as tumor imaging agents: synthesis and biodistribution studies

Biodistribution and dosimetry results from a phase III prospectively randomized controlled trial of zevalinradioimmunotherapy for low-grade, follicular, or transformed B-cell non-hodgkin's lymphoma

Bone scan index at baseline as a tool for predicting hematologic toxicity in metastatic castration-resistant prostate cancer patients eligible for radium-223 treatment

Chapter 104 - 131Iodine in Thyroid Cancer: Use of 131I in the Diagnosis and Therapy of Differentiated Thyroid Carcinoma

Clinical and Genetic Factors Underlying Acute Bone Mineral Density Loss by 100 Days after Blood and Marrow Transplantation: A Potential Early Regimen-Related Complication

A Comparative Study of 511 keV SPECT and PET Using Separate 370 MBq F-18-FDG Doses on Different Days

Comprehensive handbook of iodine: nutritional, biochemical, pathological, and therapeutic aspects

Disease Control Affects Outcomes of Patients with Relapsed Diffuse Large B Cell Lymphoma Treated with CD19 Directed CAR T-Cell Therapy

(18)F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study

High Frequency and Early Onset of Bone Mineral Density Loss Following Allogeneic Stem Cell Transplantation

Immunomodulation by entinostat in renal cell carcinoma patients receiving high dose interleukin 2: a multicenter, single-arm, phase 1/2 trial (NCI-CTEP#7870)

Immunomodulation by HDAC inhibition: Results from a phase II study with entinostat and high-dose interleukin 2 in metastatic renal cell carcinoma patients (CTEP#7870)

Iodine 131 ((131)I) as adjuvant therapy of differentiated thyroid cancer

Iodine 131 ( 131I) as adjuvant therapy of differentiated thyroid cancer

Mammographic and clinical predictors of drainage patterns in breast lymphoscintigrams obtained during sentinel node procedures

Aktive Filter

Suchergebnisse filtern